Vasoactive Peptides in Portal Pressure
NCT00163982 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2007-07-26
Summary
This study is looking at the detection of vasoactive peptides in portal hypertension.
Conditions
- Portal Hypertension
Interventions
- DRUG
-
Norfloxacin
Sponsors & Collaborators
-
Bayside Health
lead OTHER_GOV
Principal Investigators
-
William W Kemp, MBBS, FRACP · The Alfred
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Australia
Study Locations
More Related Trials
-
Comparative Efficacy of Various Non-invasive Methods in Assessing Response to Beta-blockers as Secondary Prophylaxis for Acute Variceal Bleed.
NCT05166317 ·Status: UNKNOWN
-
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)
NCT04863703 ·Status: ACTIVE_NOT_RECRUITING
-
WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis
NCT03195634 ·Status: UNKNOWN
-
Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
NCT00344916 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.
NCT00794482 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
NCT00534677 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Probiotics (VSL) on Portal Hypertension
NCT01032941 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage
NCT03846180 ·Status: COMPLETED
-
Portal Hypertension and Systemic Endothelial Function
NCT02850692 ·Status: UNKNOWN ·Phase: NA
-
Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
NCT05767229 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices
NCT02583698 ·Status: COMPLETED ·Phase: NA
-
Microparticles in Cirrhosis and Portal Hypertension
NCT02859610 ·Status: COMPLETED ·Phase: NA
-
RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
NCT03061604 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Portal and Hepatic Vein Pressure Estimation
NCT06210178 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
NCT01188733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Continuous Infusion of Terlipressin vs Bolus Terlipressin in ACLF Patients With Acute Esophageal Variceal Bleed
NCT06815770 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312 ·Status: COMPLETED
-
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
NCT00359853 ·Status: COMPLETED ·Phase: PHASE4
-
TIPS for PH Patients: an Observational, Cohort Study
NCT06221982 ·Status: RECRUITING
-
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
NCT04724148 ·Status: UNKNOWN ·Phase: NA
-
Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
NCT01059396 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Outcome After H-graft Shunt Placement
NCT00519610 ·Status: COMPLETED
-
Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response
NCT01530711 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
NCT05161481 ·Status: TERMINATED ·Phase: PHASE2